Cargando…

The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan

BACKGROUND: The Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT) is a trial to determine the clinical efficacy and safety of omalizumab for children with severe atopic eczema. This article describes the detailed statistical analysis plan for the ADAPT as an update to the published protocol and is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tao, Chan, Susan, Lack, Gideon, Cro, Suzie, Cornelius, Victoria R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442690/ https://www.ncbi.nlm.nih.gov/pubmed/28535776 http://dx.doi.org/10.1186/s13063-017-1976-6

Ejemplares similares

Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial
por: Chan, Susan, et al.
Publicado: (2017)

Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial
por: Cro, Suzie, et al.
Publicado: (2018)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial
por: Cro, Suzie, et al.
Publicado: (2020)

A randomised, multi-centre trial of total ankle replacement versus ankle arthrodesis in the treatment of patients with end stage ankle osteoarthritis (TARVA): statistical analysis plan
por: Muller, Patrick, et al.
Publicado: (2020)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)

Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells
por: Chan, Marcia A, et al.
Publicado: (2013)

Current approaches to handling rescue medication in asthma and eczema randomized controlled trials are inadequate: a systematic review
por: Chis Ster, Anca Maria, et al.
Publicado: (2020)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Hyfrecation for Recalcitrant Nongenital Warts
por: Leung, Lawrence
Publicado: (2013)

USE OF METHOTREXATE IN RECALCITRANT ECZEMA
por: Mittal, Asit, et al.
Publicado: (2011)

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
por: Davies, Anna M., et al.
Publicado: (2017)

Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2023)

Research statistics in Atopic Eczema: what disease is this?
por: Hon, Kam-Lun Ellis, et al.
Publicado: (2012)

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007)

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization
por: Mitropoulou, Alkistis N., et al.
Publicado: (2020)

Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study
por: Chen, Hao-Cheng, et al.
Publicado: (2016)

Detailed statistical analysis plan for the pulmonary protection trial
por: Buggeskov, Katrine B, et al.
Publicado: (2014)

Hyper IgE in Childhood Eczema and Risk of Asthma in Chinese Children
por: Ng, Chantel, et al.
Publicado: (2016)

PRECISE — pregabalin in addition to usual care: statistical analysis plan
por: Mathieson, Stephanie, et al.
Publicado: (2016)

Detailed statistical analysis plan for the difficult airway management (DIFFICAIR) trial
por: Nørskov, Anders Kehlet, et al.
Publicado: (2014)

Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan
por: Westendorp, Willeke F, et al.
Publicado: (2014)

STeroids Against Radiculopathy (STAR) trial: a statistical analysis plan
por: ter Meulen, Bastiaan C., et al.
Publicado: (2021)

A phase III, multi-centre, double-masked randomised controlled trial of adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): statistical analysis plan
por: Lo, Jessica W., et al.
Publicado: (2016)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

Serum free IgE guided dose reduction of omalizumab: a case report
por: Gon, Yasuhiro, et al.
Publicado: (2017)

Atopic Eczema
por: Wright, Stephen
Publicado: (1991)

Levels of total serum IgE and specific IgE sensitization profile in patients with atopic dermatitis
por: Poleshuck, Rafael Teixeira Figueredo, et al.
Publicado: (2015)

Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT)
por: Johnsen, Anna Thit, et al.
Publicado: (2014)

Update on the Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II): statistical analysis plan
por: Gregson, Barbara A, et al.
Publicado: (2012)

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study
por: Eckl‐Dorna, J., et al.
Publicado: (2017)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

IgE-Selective Immunoadsorption for Severe Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

Influence of atopic history on cord blood IgE
por: Kashef, Mohammad Amin, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_1jhbg8cq2ku91qf6ggunqp3p21